OLIG2 and central nervous system cancer: In addition, we also observed subtle changes in tumor composition, such as an expansion of non-tumor oligodendrocyte-progenitor cells, a more pronounced NPC-like cell compartment, and an increase of vessel co-opting OLIG2+ glioma cells at the tumor leading edge, as well as more dramatic alterations, like the higher abundance of polarized myeloid cells.